J2711 Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg

Short descriptor: Inj neostigmin/glycopyrrolat

✓ Active HCPCS Level II 2026
Open J2711 in the app →

Look up J2711 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.

J2711 is the HCPCS Level II code for Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg (2026). It belongs to Section J — Drugs Administered Other Than Oral Method. Under Medicare, its coverage status is: Carrier judgment. Part B pricing methodology: Drugs.

Classification & CMS Attributes

Medicare Coverage
Carrier judgment (code C)
Part B Pricing
Drugs (indicator 51)
Type of Service
Medical care
Effective Date
2026-01-01
2026 Maintenance
Added this year

Drug Details

Drug / Substance
neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg
Route
Injection

See the full HCPCS Table of Drugs (J-codes).

References

Cite This Page

Reference J2711 with the canonical source and edition:

J2711 — Injection, neostigmine methylsulfate 0.1 mg and glycopyrrolate 0.02 mg. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/J2711

Canonical URL: https://icd10codingpro.com/hcpcs-codes/J2711

Related Codes in Section J

Browse all HCPCS Level II sections →
Reviewed by Prajwal Shrestha, CPC, CRC
Certified Professional Coder (CPC) and Certified Risk Adjustment Coder (CRC) · AAPC Member ID 01997614 · About · Editorial policy · Content last reviewed: 2026-01-01

Get HCC Mappings, Clinical Summaries, and More

Access premium features including HCC risk adjustment, FDA drug indications, AI coding assistant, and comprehensive clinical context.

Start Free Trial